REBECCA HOOD: Open Payments
NPI 1649880675 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,868 in 149 payments from 42 companies in 2025. Trend: 2023 $2,204 · 2024 $2,390 · 2025 $6,868
Food & beverage: $4,483Travel & lodging: $2,274Education: $92Gift: $20
| Company | Payments | Amount |
|---|---|---|
| OnMark, Inc. | 10 | $3,732 |
| Janssen Biotech, Inc. | 14 | $317 |
| AstraZeneca Pharmaceuticals LP | 13 | $290 |
| Novartis Pharmaceuticals Corporation | 13 | $251 |
| Tempus AI, Inc | 8 | $211 |
| Daiichi Sankyo Inc. | 8 | $202 |
| ABBVIE INC. | 6 | $177 |
| Merck Sharp & Dohme LLC | 8 | $173 |
| GlaxoSmithKline, LLC. | 5 | $116 |
| Incyte Corporation | 5 | $100 |
Products named: XT CDX, Enhertu, KEYTRUDA, ERLEADA, EPKINLY, KISQALI, TALVEY, IMFINZI.
Industry payments across LA — which companies pay providers there.
